within Pharmacolibrary.Interfaces;
partial model PartialEffect
  //extends Pharmacolibrary.Interfaces.PartialOneConcPort;
  //parameter Boolean cBSwitch = false "false: use tissue free conc, true: use blood free conc";
  Modelica.Units.SI.DimensionlessRatio E "efect";
  Pharmacolibrary.Types.MassConcentration Ce "effect site conc";
  parameter Pharmacolibrary.Types.TransferRate ke(displayUnit="1/h")=1;
  ConcentrationPort_a cport annotation(
    Placement(transformation(origin = {0, 98}, extent = {{-10, -10}, {10, 10}}), iconTransformation(origin = {0, 100}, extent = {{-20, -20}, {20, 20}})));
  Modelica.Blocks.Interfaces.RealOutput effect annotation(
    Placement(transformation(origin = {102, 2}, extent = {{-10, -10}, {10, 10}}), iconTransformation(origin = {102, 2}, extent = {{-10, -10}, {10, 10}})));
equation
  //c = cport.c;
  der(Ce) = ke * (cport.c - Ce);
  //c_out = Ce;
  cport.qm = 0;
  effect = E;
  annotation(
    Icon(graphics = {Polygon(origin = {12, -1}, lineColor = {152, 112, 187}, fillColor = {255, 255, 255}, fillPattern = FillPattern.Solid, lineThickness = 4, points = {{-28, 99}, {-62, 1}, {42, -11}, {-20, -99}, {86, 3}, {-26, 15}, {16, 99}, {-28, 99}, {-28, 99}})}),
    Documentation(info = "<html><body><h4>PartialEffect</h4><p>Base for a <b>pharmacodynamic (PD) effect</b> component. It reads the drug concentration at <code>cport</code> and drives an effect-site concentration with first-order equilibration:</p><pre>  der(Ce) = ke * (cport.c - Ce)   // effect-site (biophase) kinetics
  cport.qm = 0                    // sensing only, draws no mass
  effect   = E</pre><p>The effect magnitude <code>E</code> and its dependence on concentration is left to the extending model &ndash; e.g. Linear, Emax, SigmoidEmax (direct, using <code>cport.c</code> or <code>Ce</code>) or the turnover models built on <code>PartialIndirectEffect</code>. Set <code>ke</code> for the biophase delay; a large <code>ke</code> makes <code>Ce</code> track <code>cport.c</code> instantly.</p></body></html>"));
end PartialEffect;
